Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Sep 2018 07:00

RNS Number : 8721A
Dairy Crest Group PLC
17 September 2018
 

17 September 2018

 

Dairy Crest Group plc ("Dairy Crest")

 

TRADING UPDATE FOR THE SIX MONTHS ENDING 30 SEPTEMBER 2018

 

Dairy Crest is issuing the following pre-close trading update for the six months ending30 September 2018, ahead of announcing its Interim Results on 7 November 2018.

 

Trading update

In the first half of the financial year we expect Group revenue to be ahead of last year, driven by strong performances from our two largest brands, Cathedral City and Clover.

 

Cathedral City's revenue is expected to deliver good growth against strong volumes a year ago. The brand continues to go from strength to strength, and was recently voted one of the top 10 brands by UK consumers in YouGov's Annual Brand Health Rankings, based on consumers' perceptions of quality, value, satisfaction and reputation, as well as being voted number one in the chilled/frozen foods category.

 

Clover is expected to deliver both volume and revenue growth, continuing the positive performance from last year.

 

In line with the broader UK oil market, Frylight is expected to show a reduction in volume and revenue for the first half of the year due primarily to the unusually hot weather which impacted oil usage. However, trading has improved significantly in recent weeks and that trend is expected to continue into the second half.

 

We have continued to restrict Country Life promotional activity while butter costs remain high, and this continues to impact sales.

 

The Functional Ingredients business continues to grow in line with our expectations.

 

 

Innovation

Dairy Crest aims to deliver 10% of its revenues from products developed within the past three years. In 2017/18, 14% of revenues came from recent innovation.

 

Clover Light with no artificial ingredients launched last month. This reformulation follows the introduction of the original Clover spread with no artificial ingredients in September 2015 and is a further response to consumers wanting more natural, less artificial products.

 

The next few months will see several new product releases for Cathedral City. As part of our continued focus on snacking, we will launch two new Cathedral City snack bars flavoured with caramelised onions and sweet chilli in October. We will also be partnering with Nickelodeon to promote our relaunched kids snacking range. In line with our strategy to cater to a diverse set of consumer needs, Dairy Crest will be rolling out a Cathedral City Lactose Free range.

 

We will shortly be unveiling a galacto-oligosaccharides (GOS) 'shot' for consumers which is marketed under the Promovita brand name. The unique prebiotic dietary fibre, which nourishes health-promoting bacteria in the gut, will be sold as liquid sachets to be taken daily.

 

Profit and financial position

We expect profit for the half year to be slightly ahead of the same period last year. Our expectations for the full year remain unchanged.

 

Following the equity issuance in May 2018, net debt will be significantly lower at the end of September 2018 compared to the same period last year.

 

Mark Allen, Chief Executive, commented:

 

"Our Cathedral City and Clover brands continue to drive the business forward, supported by an exciting pipeline of new product developments. For Cathedral City to be named one of the UK's top ten brands by consumers, alongside John Lewis, Amazon and Ikea, is testament to the power of the UK's favourite cheese brand, and we see good growth potential in the UK and beyond.

 

"Innovation is the cornerstone of this business and we're looking forward to showcasing a number of examples at our Capital Markets event this week. Our Functional Ingredients business is progressing well and we are excited by the potential of the launch of the Promovita GOS 'shot'.

 

"Our balance sheet is in good shape and we are moving forward with the first phase of the expansion at Davidstow. Our expectations for the full year remain unchanged."

 

 

ENDS

 

Dairy Crest is hosting a site visit for analysts and investors to its Innovation Centre on the campus of Harper Adams University on Monday 17 and Tuesday 18 September 2018. The management team will make presentations on this trading update, key brands and innovation. These will be made available on Dairy Crest's website at www.dairycrest.co.uk/investors. No material new information will be disclosed in these presentations.

 

Dairy Crest expects to issue its Interim Results for the six months ended 30 September 2018 on 7 November 2018.

 

For further information:

 

Dairy Crest

Tom Atherton 01372 472264

Kate Goode 01372 472236

 

Brunswick

Tim Danaher / Alison Kay 020 7404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUSSSRWAAKAAR
Date   Source Headline
22nd Feb 20192:11 pmRNSForm 8.3 - Dairy Crest Group plc
22nd Feb 201911:51 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - [Insert name of offeree or offeror]
22nd Feb 201911:10 amPRNForm 8 (OPD) - Dairy Crest Group Plc
22nd Feb 201910:40 amRNSForm 8.3 - Dairy Crest Group Plc
22nd Feb 20197:14 amRNSRecommended Cash Acquisition of Dairy Crest plc
5th Feb 201910:25 amRNSPCA Dealing
1st Feb 20192:43 pmRNSDirector/PDMR Shareholding
31st Jan 20199:58 amRNSTotal Voting Rights
31st Jan 20197:00 amRNSTrading Statement
7th Jan 20193:44 pmRNSDirector / PDMR Shareholding
2nd Jan 20199:47 amRNSTotal Voting Rights
30th Nov 201811:01 amRNSTotal Voting Rights & Capital
7th Nov 20189:09 amRNSCorrection: Interim results
7th Nov 20187:00 amRNSInterim Results
2nd Nov 201811:21 amRNSNotification of Major Holdings
2nd Nov 201811:20 amRNSNotification of Major Holdings
31st Oct 201810:37 amRNSTotal Voting Rights & Capital
17th Oct 20183:35 pmRNSStandard form for notification of major holdings
11th Oct 20182:20 pmRNSStandard form for notification of major holdings
28th Sep 201812:34 pmRNSTotal Voting Rights & Capital
18th Sep 201810:27 amRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSTrading Update
31st Aug 20187:00 amRNSTotal Voting Rights & Capital
20th Aug 20183:26 pmRNSDirector/PDMR Shareholding
13th Aug 20185:15 pmRNSDirector / PDMR Shareholding
6th Aug 20184:43 pmRNSDirector / PDMR Shareholding
31st Jul 201812:04 pmRNSTotal Voting Rights & Capital
18th Jul 20189:54 amRNSResult of AGM
17th Jul 20187:00 amRNSAGM and Trading Update
12th Jul 201811:54 amRNSBlock listing application
6th Jul 20185:01 pmRNSDirector/PDMR Shareholding
29th Jun 201812:56 pmRNSTotal Voting Rights & Capital
28th Jun 201810:18 amRNSDirector Dealing
21st Jun 201810:09 amRNSDirector and PCA Dealing
20th Jun 20182:05 pmRNSBlock listing Interim Review
19th Jun 201811:57 amRNSTR-1: Notification of major holdings
15th Jun 20185:30 pmRNS2018 Annual Report and Accounts and Notice of AGM
8th Jun 201812:39 pmRNSDirector and PCA Dealing
1st Jun 20189:49 amRNSTotal Voting Rights & Capital
31st May 201810:38 amRNSDirector / PDMR Shareholding
23rd May 201810:01 amRNSRESULT OF PLACING OF NEW ORDINARY SHARES
23rd May 20187:01 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
23rd May 20187:00 amRNSPreliminary Results
10th May 20184:08 pmRNSBlock Listing Application
10th May 20182:33 pmRNSNon-executive Director Appointment
30th Apr 20181:47 pmRNSTotal Voting Rights & Capital
29th Mar 20182:09 pmRNSTotal Voting Rights & Capital
28th Feb 201811:19 amRNSTotal Voting Rights & Capital
16th Feb 20185:10 pmRNSDirector/PDMR Shareholding
9th Feb 201812:24 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.